代表性论文

Hong Wu; Juan Ge; Fengming Zou; Zongru Jiang; Beilei Wang; Xinyu Yuan; Kaili Long; Jing Liu; Wenchao Wang; Qingsong Liu; Pharmacological inhibiting STAT5 for the treatment of FLT3‐ITD‐positive acute myeloid leukemia with triciribine phosphate monohydrate, MedComm, 2023,4(4).

Husheng Mei; Hong Wu; Jing Yang; Bin Zhou; Aoli Wang; Chen Hu; Shuang Qi; Zongru Jiang; Fengming Zou; Beilei Wang; Feiyang Liu; Yongfei Chen; Wenchao Wang; Jing Liu; Qingsong Liu; Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies, Signal Transduction and Targeted Therapy, 2023, 8(1).

Jiang-yan Cao; Shuang Qi; Hong Wu; Ao-li Wang; Qing-wang Liu; Xi-xiang Li; Bei-lei Wang; Juan Ge; Feng-ming Zou; Cheng Chen; Jun-jie Wang; Chen Hu; Jing Liu; Wen-chao Wang; Qing-song Liu; CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers, Acta Pharmacologica Sinica, 2022, 43(10): 2678-2686.

Chen, Cheng; Cheng, Chuan-dong; Wu, Hong; Wang, Zuo-wei; Wang, Li; Jiang, Zong-ru; Wang, Ao-li; Hu, Chen; Dong, Yong-fei; Niu, Wan-xiang; Qi, Shuang; Qi, Zi-ping; Liu, Jing; Wang, Wenchao;Niu, Chao-shi; Liu, Qing-song; Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway, Acta Pharmacologica Sinica, 2021, 42(1): 108-114.

H Wu; A Wang; Z Qi; X Li; C Chen; K Yu; F Zou; C Hu; W Wang; Z Zhao; J Wu; J Liu; X Liu; L Wang; W Wang; S Zhang; R M Stone; I A Galinsky; J D Griffin; D Weinstock; A Christodoulou; H Wang; Y Shen; Z Zhai; E L Weisberg; J Liu; Q Liu; Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML, Leukemia, 2016, 30(10): 2112-2116.

承担项目

中国科学院青年创新促进会优秀会员项目，Y2023125，2023.12-2026.12主持，在研

中国科学院青年创新促进会，2019.01-2021.01，2019437，主持，已结题

国家自然科学基金青年基金项目，2018.01-2020.12，81703559，依鲁替尼衍生物MM2-48在急性髓细胞性白血病中的新靶点发现及作用机制初探，主持，已结题

安徽省省自然科学基金面上项目，2018.08-2021.06，1808085MH274，依鲁替尼衍生物在急性髓细胞性白血病中的新靶点发现及作用机制初探，主持，已结题